Module 1: Introduction and Pre-Polls:Dr. Shubhi from Medical Learning Hub welcomed all the participants, speakers Dr. Meenu Walia, Dr. Saurabh Mishra; panelists Dr. Piyush Gupta and Mr. AK Singh. The first poll was raised.
Module 2: Quality of Life After Hodgkin's Lymphoma Treatment:Dr. Saurabh Mishra, Director & CEO of Synergy Superspeciality Hospital and Cancer Institute, Gorakhpur, led this session. Key points of discussion included:
- Long-term HL
- Current survivorship recommendations
- Risks and risk factors of late Hodgkin's lymphoma
- Efficacies of screening strategies
- Selected late effects of HL
- Chronic late effects
- Follow-up for HL
- Recommendations for HL
Module 3: Advancements in Hodgkin's Lymphoma Treatment:Dr. (Prof.) Meenu Walia, Vice-Chairman of Oncology at Clinical Cancer Care, Max Institute of Cancer Care, Max Healthcare, presented this module. Key points of discussion were:
- About Hodgkin's disease
- Global statistics
- Indian statistics
- Pathological features
- Diagnosis
- Tissue diagnosis
- Risk-adaptive treatment
- Response-adaptive treatment
- NCCN guidelines version
Module 4: Question and Answer:Several questions were asked by the audience, all of which were answered by Dr. Meenu and Dr. Saurabh.
Module 5: Vote of Thanks:Dr. Piyush from Cancer Aid Society delivered the vote of thanks. The second poll was raised.
We wish you a great learning experience!
This educational event is made possible by a charitable grant from Bristol Myers Squibb
- Introduction & welcome note:
- Speaker 1: Advancements in Hodgkin's Lymphoma Treatment: Dr (prof) Meenu Walia, Vice-Chairman-Oncology, Clinical cancer care, Max Institute of Cancer Care, Max Healthcare
- Speaker 2: Quality of Life After Hodgkin's Lymphoma Treatment & case presentation: Dr. Saurabh Mishra, Director & CEO, Synergy Superspeciality Hospital and Cancer Institute, Gorakhpur
- Question & Answer
- Vote of thanks
Final year MBBS students, Students of hematology department, Internees, PG students from department of Hematology, Oncology, Medicine, Pediatrics, Pathology, Hematologist, Oncologist, Onco surgeon, Pediatrician, pathologist, consultants. Other doctors and healthcare providers who may benefit from this learning opportunity.
